Canada’s COVID-19 vaccine rollout requires a shift in approach

Canada’s COVID-19 vaccine rollout requires a shift in approach


No alt text provided for this image

I often stand by Aesop’s adage slow and steady wins the race, seeking to embed the tortoise’s principles of patience and earnestness into my professional and personal lives. However, when it comes to Canada’s COVID-19 vaccine rollout, I’m increasingly finding myself wishing for the pace and haste of the hare.

This doesn’t mean cutting corners. Instead, it means greater urgency, confidence and speed – straight out of the gate.

Despite Canada ordering the world’s largest number of vaccine doses per capita (including the two approved Pfizer and Moderna vaccines), our efforts have been outpaced by 11 other OECD countries. According to Our World in Data, collected by the University of Oxford, vaccination doses administered in Canada currently sits at just 2.23 per 100 people.

No alt text provided for this image

Why is Canada lagging? We administered our first vaccine on December 14, 2020 - 43 days ago. That means we’ve had over six weeks to vaccinate people. Yet, Canada isn’t treating vaccinations with the highest priority it deserves.

Canadians have been begging pharmaceutical companies to develop and ship more vaccines and to do so more quickly. Even then, when Canada did have vaccines sitting in freezers, we were slow to actually get the shots into peoples’ arms. For example, Ontario startlingly shut down its vaccination clinics over the holidays. From the very beginning, we’ve missed an opportunity to mobilize every government employee to help manage the provinces’ and country’s vaccination efforts. All necessary resources should be diverted to help the rollout effort. 

Now, we are facing a supply shortage caused by delays. But the country can’t afford to sit back. Where I live and work, the City of Toronto opened and closed its pilot vaccination clinic at the Metro Convention Centre (in a two-day span) because there were no vaccines to administer. Why not use the time to test run the process on a massive scale? For those who haven’t gotten the flu shot, it’s a great opportunity to immunize and test the process. Or, in the absence of any jabs, public health officials could practice and identify the kinks and iron them out immediately.

The federal government says that all Canadians who want a vaccine will be able to receive a dose by the end of September. But if we see new vaccine delays, hiccups in logistics or other changes, what’s the back-up plan? Although the Pfizer slowdown is temporary and will ultimately enable significantly higher production later this year, it highlights the need to be adaptable and efficient.

Canada is the second largest country by land mass with many rural and remote areas. Nevertheless, we can learn a great deal from other nations. Other countries have made inoculation a top national priority, and underscored it with urgency, innovation and conviction.

Leading the world in the number of vaccines given per capita is Israel. Despite starting immunizations a week after Canada, it has vaccinated 25 per cent of its population. Israel paid a premium to secure a huge supply of the Pfizer-BioNTech vaccine and has since been delivering it around-the-clock. With 150 vaccine complexes plus a drive-in vaccination site, the country is an incredible example of efficiency and speed.

Israel also appears to be tackling a 21st century problem with modern tactics. The country is using social media, texting and phone calls to send messages to the general population, schedule appointments and send reminders for follow-up shots. Canada should use this time of shortages to set up and test a similar strategy, incorporate Amber Alerts and work through any glitches. Additionally, instead of involving its military like Canada, Israel is using its existing healthcare administration, plus technology, to maintain simple and swift logistics.

Similarly, the U.S. is vaccinating nearly one million people per day. The U.K. is also delivering its three approved vaccines at a rapid pace, with some regions inoculating nearly 300,000 people a day.  By contrast, Canada is set to receive just over 171,000 vaccine doses over the next two weeks. As a country, we are receiving fewer doses of vaccine per week than one region in the U.K. is vaccinating per day.

Another large reason for Britain’s success is its growing army of citizen volunteers. Why isn’t Canada using a similar model to fan out its existing supply?

Meanwhile, Denmark’s vaccination program is taking the lead in the EU. Vaccines were administered in all the country’s elderly care centres within a couple of weeks of initial rollout – with experts citing the country’s digital capabilities as a factor in its success. Denmark has a centralized database that helps health officials determine vaccination priorities. The Danes are also accustomed to communicating with authorities electronically – streamlining processes and communication.  

While comparing countries (and even Canada’s own provinces) is not a black and white task, we must look to our peers for key learnings. When there are lives at stake, we cannot afford to meander like the tortoise, and sit back and wait. Let’s use the time of shipment delays wisely to ensure we stay on track. The Globe and Mail’s André Picard puts it perfectly: “If we’re going to treat pandemic patients 24/7, we should be doing pandemic prevention in the form of vaccination 24/7 as well.”

Let’s remember our own strong history of medical innovation. Canada’s Banting and Best are the icons behind insulin; Dr. James Till and Dr. Ernest McCulloch are the brains behind transplantable stem cells. We are responsible for a number of medical breakthroughs and must similarly meet this moment.

Our healthcare workers are doing an unimaginable job. Those on the frontlines continually put their own fears aside and relentlessly show up for others. These brave people deserve our strongest commitment and the grandest parade in the history of this country, once life is sort-of back to normal. Ramping up our vaccination efforts is supportive not only of them, but our seniors and our country as a whole. 

Rita Winn

Director at Lovell Drugs Limited/ President WINN-RX LTD

4y

Well said! Thanks Helen!

Like
Reply
Janneke G.

RPN in LTC/Practicum Clinician/Respite Provider

4y

Thanks for this insight. As a Health Care Worker in LTC in Ontario and being surrounded by people who think the vaccine is dangerous, the silver lining of the delay is that it has given me time. Time for me to gather well sourced information, talk to those people who are against it and make an informed decision. One of my questions is: lf the vulnerable have received the vaccine (97% in the home I work have received their 1st) why should I? (Kinda like pneumovax and shingles vaccine)

Like
Reply
Tami Crawley

Consultant :Pharma and Device Market Access, Drugs and Devices, Government and Stakeholder Relations, HTA, pCPA.

4y

dead on the mark!

Like
Reply

Helen, well stated in this thoughtful analysis. I am thankful to have received the first dose of the Pfizer vaccine, but am delayed I getting dose #2 to 42 days. We had heard rumblings of “wasted” doses at the end of the day in slots that could not be filled. Our initial appointment was by “random” from a pool of the most critical front line workers impacted and we had to wait for a phone call as to when our appointment would be scheduled. The US is using a needle system that can provide 6 doses/vial. We are using syringes that provide 5 doses/vial. These small things have an impact when the numbers increase by 10’s of thousands. It did not seem as though there was a lot of preparation/coordination prior to people getting vaccinated; sadly, we are feeling that impact now.

Like
Reply
Jason Knecht, CCSS

Customer Success, Account Management, Consulting & Analytics

4y

Although not perfect, I feel like the provinces (at least Quebec where I am from) are managing the roll-out rather well. The issue is procurement, which the Feds have dropped the ball on. Instead of aggressively negotiating with several manufacturers and ensuring contracts are met, they decided to negotiate more inventory than our country can possibly manage. I'm not saying it was a bad strategy by diversifying the portfolio, however saying we have agreements with everyone, yet no one delivers is worthless. Canada needs to stop 'being Canadian' in this case and worry about Canadians first. We should be firm on contracts that can be filled and should also be investing heavily investing in Canadian manufacturers. Even if we are late, it's better to focus on the bigger nationalist strategy as we still have far to go and will unlikely not be the last time we are in this situation.

To view or add a comment, sign in

Others also viewed

Explore content categories